Drug Discovery World

OCTOBER 4, 2022

This year’s event will cover some of the most exciting advancements in areas spanning screening, automation, high content imaging, disease models, cell and gene therapies and how innovation is being driven through partnerships and collaborations. Cell and gene therapies. In 2021, levels of investment hit an all-time high at $22.7

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

XTalks

DECEMBER 20, 2023

‘No Time to Wait’ Ad Campaign from BMS-Pfizer Features Basketball Legend Kareem Abdul-Jabbar for AFib Awareness As pharma TV advertising remained popular in 2023, so did partnerships between pharma companies and celebrities for disease and drug campaigns. billion in 2022.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

DECEMBER 29, 2022

For example, on the pharma and biotech side, there has been growing demand for new drugs and biologics, from new classes of dual-action diabetes and weight loss drugs like Ozempic and Mounjaro to life-saving gene therapies. 1. Cell and Gene Therapies. Here are four life sciences trends to look out for in 2023.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

pharmaphorum

NOVEMBER 16, 2020

During his tenure the EMA also implemented new rules to encourage the development of advanced therapy medicinal products (ATMPs) like gene and cell therapies, and the introduction of the PRIME fast-track review for promising medicines. Emer Cooke.

Regulation 64

Regulation Medicine Vaccination Vaccine 64

pharmaphorum

DECEMBER 29, 2022

Today, with more crises potentially awaiting around the corner, companies recognise how smart manufacturing improves efficiency and visibility across processes, boosting timely, global access to medicines, vaccines, and diagnostics, including those in low- and middle-income countries. Crisis readiness and digital workflows.

Manufacturing 105

Manufacturing Medicine Pharma Companies Engineer 105

Pharmaceutical Technology

SEPTEMBER 8, 2022

The use of single-use bioprocessing technology in the pharma industry effectively helps in cost reduction, increasing productivity, saving energy, water and time, as well as easier disposal. The post Leading API biologics (cell, gene, vaccine and virus) companies in contract marketing appeared first on Pharmaceutical Technology.

Gene 100

Gene Marketing Vaccination Vaccine 100

XTalks

OCTOBER 15, 2021

The cell line, called HeLa, laid the foundation for many groundbreaking discoveries, including vaccines for the human papilloma virus (HPV) and polio; drugs for HIV and cancers; gene mapping; IVF treatment; and more recently, for crucial COVID-19 research. Fittingly, it was also used to develop the vaccine against cervical cancer.

Vaccination 105

Vaccination Vaccine Gene Mapping Doctors 105

XTalks

OCTOBER 22, 2020

In this sense, pharmaceutical companies have developed different strategies to produce a wide variety of advanced therapy medicinal products (ATMP) and biological products, such as monoclonal antibodies, recombinant proteins, gene therapy viral vectors, CAR-T cells and oncolytic viruses, in order to deliver new medical needs in our society.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

XTalks

MARCH 22, 2023

While not a record-breaking deal at $17 billion, the buyout strengthened Pfizer’s injectables business unit with the company reporting an 11 percent increase in revenue the following year. Pfizer is also the co-developer of what is arguably the most successful COVID-19 vaccine rollout.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

DECEMBER 22, 2021

The RNA Revolution: From mRNA Vaccines to RNA Editing. RNA, and its protein-generating form messenger RNA (mRNA) discovered in 1961 , has quickly transitioned from being an obscure, finicky molecule that is difficult to work with, to becoming a significant cornerstone of therapeutic innovation in pharma and biotech.

Life Science 98

Life Science RNA Vaccination Vaccine 98

XTalks

APRIL 16, 2024

The drug is a calcitonin gene-related peptide (CGRP) receptor inhibitor that blocks CGRP receptors in the brain to reduce migraine symptoms of headache, nausea, vomiting, light sensitivity and sound sensitivity. Backlash against celebrities for partnering with pharma companies isn’t new.

Drugs 52

Drugs Pharma Companies Doctors Doctor 52

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade.

Marketing 78

Marketing Gene Silencing Gene Drugs 78

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. The AI Drug Development Division is focused on AI-guided design and development of individualised neoantigen vaccines in oncology. .

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

pharmaphorum

JANUARY 10, 2022

The arrival of COVID-19 brought precious few positives, but one that emerged for the pharmaceutical industry was the emergence and validation of mRNA vaccine technology to prevent disease. Pfizer already has a head start on competitors in the field, having achieved the first US FDA approval for an mRNA vaccine, alongside BioNTech.

RNA 107

RNA Vaccination Vaccine Pharma Companies 107

Drug Discovery World

MARCH 29, 2023

The commission is looking to put more pressure on pharma companies to report such shortages, and to offer a drug’s marketing authorisation to another company before withdrawing it from the market. This looks like it may change shape in the future for the region, if the proposal put forward by the commission is adopted.

Clinical Trials 52

Clinical Trials Clinical Trials Production Medicine 52

pharmaphorum

NOVEMBER 23, 2022

We looked at the areas of rare diseases, cell and gene therapy, vaccines – loads of different perspectives. It also benefits pharma companies: instead of highly skilled reviewers spending time reviewing basic errors, identifying grammatical errors in documents, they no longer need to focus on that.

Life Science 98

Life Science Marketing Medicine Production 98

Drug Discovery World

NOVEMBER 16, 2022

On the point of consistency, the fact that organoids are a relatively new technology means that there isn’t a set ‘baseline’ in how companies grow them, with the differentiation potentially affecting research undertaken with them. “One One of the biggest pain points is really the consistency of organoids. O’Connor says.

Drugs 97

Drugs In-Vivo In-Vitro Scientist 97

Drug Discovery World

JANUARY 26, 2023

Research into HIV blossomed throughout 2022, with ViiV Healthcare’s combination therapy for HIV-1 gaining approval in Japan; and research moving forward towards a one-time treatment for HIV as well as a vaccine. According to research from Deloitte 1 , the average ROI in R&D for global pharma companies fell to just 1.2%

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Pharmaceutical Technology

SEPTEMBER 26, 2022

Both Sandoz and Novartis are internationally renowned pharma companies, with a combined 34 production facilities worldwide. On 30 September 2015, GSK agreed to pay $5.25bn for Novartis's vaccines business, while Novartis purchased GSK's oncology division for $16bn. stake in their consumer healthcare joint venture for $13bn.

Manufacturing 162

Manufacturing Drugs Branding Sales 162

World of DTC Marketing

JANUARY 31, 2021

The venture capitalists funding them are looking for a big payday when a pharma company acquires them. I have been recruited by these companies who promise huge payouts when they are acquired if their drug shows promise in clinical trials. In pharma R&D returns have declined to 1.8 percent—a slight decrease of 0.1

In-Vivo 187

In-Vivo Generic Drugs Gene Therapy Drugs 187

Drug Discovery World

APRIL 27, 2023

Dr Mansley also comments that the multitude of biotech and pharma companies in the Greater Boston region means that people regularly move organisations. She said: “When one of our customers leaves a company and moves to a new one up the street, they often get in touch with us, which helps us grow new business.

Life Science 52

Life Science Drugs Research Gene Splicing 52

Drug Discovery World

NOVEMBER 15, 2022

Even as methods in DNA synthesis continue to advance, scientists’ reliance on third-party companies for synthesising DNA creates a bottleneck, impeding research timelines. . “If If you want to order gene-length sequences, rather than short oligos for PCR, the waiting times are around two or three weeks at least.

DNA 98

DNA Drugs Antibody Engineer 98

Drug Discovery World

AUGUST 5, 2022

One indirect effect of the Covid pandemic – and the successful development of numerous vaccines at unprecedented speed – has been a greater-than-ever demand for new, effective medicines to be developed more quickly and efficiently, without compromising on safety. Why sponsors use external consultants.

Development 52

Development Drugs Production Gene Therapy 52

Drug Discovery World

AUGUST 8, 2023

According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2. To many, the country is referred to as the ‘pharmacy of the world’. So, what is driving this success, and will it continue?

Research 52

Research Drugs Genome Genomics 52

pharmaphorum

SEPTEMBER 1, 2020

With CAR-T (chimeric antigen receptor T-cell) drugs, pharma companies have taken the idea one step further and have been able to genetically modify the patient’s own cells to fight cancer.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

The Pharma Data

DECEMBER 30, 2020

Food and Drug Administration (FDA), noted in December 2020 that he expected the pandemic could “effectively” be ended in 2021 with the launch of the Pfizer-BioNTech and Moderna vaccines. AstraZeneca and University of Oxford COVID-19 vaccine authorization. Johnson & Johnson’s COVID-19 vaccine. Now that in the U.S.

Vaccination 52

Vaccination Vaccine Gene Therapy Trials 52

Pharmaceutical Technology

MARCH 20, 2023

Pharma companies and world health stand to benefit from new technologies, but it’s a tough time to be an investor – and an even tougher one for firms seeking investment. The mRNA technology that enabled the largest and fastest vaccine rollout in history is the tip of the innovation iceberg.

Gene Therapy 225

Gene Therapy Genome Genomics Gene 225

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. For cell and gene therapies, four companies are operating five facilities.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

MAY 26, 2023

Enzymatic DNA production company Touchlight have augmented its DNA production capabilities with a newly announced expansion to its London facilities. Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines.

DNA 130

DNA Manufacturing Gene Therapy Gene 130